India has bid a fond farewell to the MiG-21, the warhorse of the Indian Air Force. But have you wondered what awaits the ...

It was the end of January, just a week after Donald Trump returned to office, when the email arrived in the inboxes of FHI ...

The rap mogul, who was found not guilty of the three serious counts in his federal indictment, will return to court for ...

For countless Nigerians who have served time behind bars, stepping out of prison is far from the freedom it promises, as a ...

Handwriting analysis is considered relatively reliable, but original documents are needed for accuracy, experts say.

See why Scholar Rock Holding Corporation remains a Strong Buy despite regulatory setbacks, with key catalysts ahead and ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

Experts assert the U.S. EB-5 program for foreign investors seeking residency is likely to remain a popular option despite ...

Harmony Biosciences Holdings faces setbacks after a failed trial and sNDA rejection. Click here to find out why HRMY is a ...

Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibo ...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...